UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
(Mark One)
| | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended
OR
| | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number
COHU, INC.
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of | (I.R.S. Employer Identification No.) |
| incorporation or organization) | |
| (Address of principal executive offices) | (Zip Code) |
Registrant's telephone number, including area code (
Securities registered pursuant to Section 12(b) of the Act:
| Title of Each Class | Trading Symbol(s) | Name of Exchange on Which Registered |
| | | |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☐
Smaller reporting company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes
As of October 19, 2021 the Registrant had
INDEX
FORM 10-Q
SEPTEMBER 25, 2021
| CONDENSED CONSOLIDATED BALANCE SHEETS |
|||||||
| (in thousands, except par value) |
| September 25, | December 26, | |||||||
| 2021 | 2020* | |||||||
|
| (Unaudited) | |||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | $ | ||||||
| Short-term investments | ||||||||
| Accounts receivable, net | ||||||||
| Inventories | ||||||||
| Prepaid expenses | ||||||||
| Other current assets | ||||||||
| Total current assets | ||||||||
| Property, plant and equipment, net | ||||||||
| Goodwill | ||||||||
| Intangible assets, net | ||||||||
| Other assets | ||||||||
| Operating lease right of use assets | ||||||||
| $ | $ | |||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
| Current liabilities: | ||||||||
| Short-term borrowings | $ | $ | ||||||
| Current installments of long-term debt | ||||||||
| Accounts payable | ||||||||
| Customer advances | ||||||||
| Accrued compensation and benefits | ||||||||
| Deferred profit | ||||||||
| Accrued warranty | ||||||||
| Income taxes payable | ||||||||
| Other accrued liabilities | ||||||||
| Total current liabilities | ||||||||
| Long-term debt | ||||||||
| Deferred income taxes | ||||||||
| Noncurrent income tax liabilities | ||||||||
| Accrued retirement benefits | ||||||||
| Long-term lease liabilities | ||||||||
| Other accrued liabilities | ||||||||
| Stockholders’ equity | ||||||||
| Preferred stock, par value; shares authorized, issued | ||||||||
| Common stock, par value; shares authorized, shares issued and outstanding in 2021 and shares in 2020 | ||||||||
| Paid-in capital | ||||||||
| Retained earnings | ||||||||
| Accumulated other comprehensive loss | ( | ) | ( | ) | ||||
| Total stockholders’ equity | ||||||||
| $ | $ | |||||||
| * Derived from December 26, 2020 audited financial statements |
The accompanying notes are an integral part of these statements.
| CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
| (Unaudited) |
| (in thousands, except per share amounts) |
| Three Months Ended |
Nine Months Ended |
|||||||||||||||
| September 25, |
September 26, |
September 25, |
September 26, |
|||||||||||||
| 2021 |
2020 |
2021 |
2020 |
|||||||||||||
| Net sales |
$ | $ | $ | $ | ||||||||||||
| Cost and expenses: |
||||||||||||||||
| Cost of sales (1) |
||||||||||||||||
| Research and development |
||||||||||||||||
| Selling, general and administrative |
||||||||||||||||
| Amortization of purchased intangible assets |
||||||||||||||||
| Restructuring charges |
||||||||||||||||
| Impairment charges |
||||||||||||||||
| Gain on sale of facilities |
( |
) | ( |
) | ||||||||||||
| Gain on sale of PCB Test business (2) |
( |
) | ( |
) | ||||||||||||
| Income (loss) from operations |
( |
) | ( |
) | ||||||||||||
| Other (expense) income: |
||||||||||||||||
| Interest expense |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
| Interest income |
||||||||||||||||
| Foreign transaction loss |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
| Gain (loss) on extinguishment of debt |
( |
) | ( |
) | ||||||||||||
| Income (loss) from continuing operations before taxes |
( |
) | ( |
) | ||||||||||||
| Income tax provision |
||||||||||||||||
| Income (loss) from continuing operations |
( |
) | ( |
) | ||||||||||||
| Income from discontinued operations |
||||||||||||||||
| Net income (loss) |
$ | $ | ( |
) | $ | $ | ( |
) | ||||||||
| Income (loss) per share: |
||||||||||||||||
| Basic: |
||||||||||||||||
| Income (loss) from continuing operations |
$ | $ | ( |
) | $ | $ | ( |
) | ||||||||
| Income from discontinued operations |
||||||||||||||||
| Net income (loss) |
$ | $ | ( |
) | $ | $ | ( |
) | ||||||||
| Diluted: |
||||||||||||||||
| Income (loss) from continuing operations |
$ | $ | ( |
) | $ | $ | ( |
) | ||||||||
| Income from discontinued operations |
||||||||||||||||
| Net income (loss) |
$ | $ | ( |
) | $ | $ | ( |
) | ||||||||
| Weighted average shares used in computing income (loss) per share: |
||||||||||||||||
| Basic |
||||||||||||||||
| Diluted |
||||||||||||||||
| Cash dividends declared per share |
$ | $ | $ | $ | ||||||||||||
| (1) |
Excludes amortization of $6,988 and $7,447 for the three months ended September 25, 2021 and September 26, 2020, respectively, and $21,133 and $21,969 for the nine months ended September 25, 2021 and September 26, 2020, respectively. |
|
|
|
| (2) |
On June 24, 2021 we completed the divestment of our PCB Test business. The divestment of this business did not qualify for presentation as discontinued operations and the results of the PCB Test business are included in continuing operations for all periods presented. See Note 12, “Business Divestitures and Discontinued Operations” for additional information on this transaction and financial statement presentation. |
The accompanying notes are an integral part of these statements.
| CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) |
||||||||||||||
| (Unaudited) |
||||||||||||||
| (in thousands) |
| Three Months Ended |
Nine Months Ended |
|||||||||||||||
| September 25, |
September 26, |
September 25, |
September 26, |
|||||||||||||
| 2021 |
2020 |
2021 |
2020 |
|||||||||||||
| Net income (loss) |
$ | $ | ( |
) | $ | $ | ( |
) | ||||||||
| Other comprehensive income (loss), net of tax: |
||||||||||||||||
| Foreign currency translation adjustments |
( |
) | ( |
) | ||||||||||||
| Adjustments related to postretirement benefits |
||||||||||||||||
| Change in unrealized gain/loss on investments |
( |
) | ( |
) | ||||||||||||
| Reclassifications due to sale of PCB Test business |
( |
) | ||||||||||||||
| Other comprehensive income (loss), net of tax |
( |
) | ( |
) | ||||||||||||
| Comprehensive income (loss) |
$ | $ | $ | $ | ( |
) | ||||||||||
The accompanying notes are an integral part of these statements.
| CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY |
| (in thousands, except par value and per share amounts) |
| Accumulated | ||||||||||||||||||||
| Common | other | |||||||||||||||||||
| stock | Paid-in | Retained | comprehensive | |||||||||||||||||
| Three Months Ended September 25, 2021 | $1 par value | capital | earnings | loss | Total | |||||||||||||||
| Balance at June 26, 2021 | $ | $ | $ | $ | ( | ) | $ | |||||||||||||
| Net income | ||||||||||||||||||||
| Changes in cumulative translation adjustment | ( | ) | ( | ) | ||||||||||||||||
| Adjustments related to postretirement benefits, net of tax | ||||||||||||||||||||
| Changes in unrealized gains and losses on investments, net of tax | ( | ) | ( | ) | ||||||||||||||||
| Exercise of stock options | ||||||||||||||||||||
| Shares issued for restricted stock units vested | ( | ) | ||||||||||||||||||
| Repurchase and retirement of stock | ( | ) | ( | ) | ( | ) | ||||||||||||||
| Share-based compensation expense | ||||||||||||||||||||
| Balance at September 25, 2021 | $ | $ | $ | $ | ( | ) | $ | |||||||||||||
| Nine Months Ended September 25, 2021 | ||||||||||||||||||||
| Balance at December 26, 2020 | $ | $ | $ | $ | ( | ) | $ | |||||||||||||
| Net income | ||||||||||||||||||||
| Changes in cumulative translation adjustment | ( | ) | ( | ) | ||||||||||||||||
| Adjustments related to postretirement benefits, net of tax | ||||||||||||||||||||
| Changes in unrealized gains and losses on investments, net of tax | ( | ) | ( | ) | ||||||||||||||||
| Exercise of stock options | ||||||||||||||||||||
| Shares issued under ESPP | ||||||||||||||||||||
| Shares issued for restricted stock units vested | ( | ) | ||||||||||||||||||
| Repurchase and retirement of stock | ( | ) | ( | ) | ( | ) | ||||||||||||||
| Impact of sale of PCB Test business | ( | ) | ( | ) | ||||||||||||||||
| Share-based compensation expense | ||||||||||||||||||||
| Sale of common stock, net of issuance costs | ||||||||||||||||||||
| Balance at September 25, 2021 | $ | $ | $ | $ | ( | ) | $ | |||||||||||||
| Three Months Ended September 26, 2020 | ||||||||||||||||||||
| Balance at June 27, 2020 | $ | $ | $ | $ | ( | ) | $ | |||||||||||||
| Net loss | ( | ) | ( | ) | ||||||||||||||||
| Changes in cumulative translation adjustment | ||||||||||||||||||||
| Exercise of stock options | ||||||||||||||||||||
| Shares issued for restricted stock units vested | ( | ) | ||||||||||||||||||
| Repurchase and retirement of stock | ( | ) | ( | ) | ( | ) | ||||||||||||||
| Share-based compensation expense | ||||||||||||||||||||
| Balance at September 26, 2020 | $ | $ | $ | $ | ( | ) | $ | |||||||||||||
| Nine Months Ended September 26, 2020 | ||||||||||||||||||||
| Balance at December 28, 2019 | $ | $ | $ | $ | ( | ) | $ | |||||||||||||
| Net loss | ( | ) | ( | ) | ||||||||||||||||
| Changes in cumulative translation adjustment | ||||||||||||||||||||
| Cash dividends - per share | ( | ) | ( | ) | ||||||||||||||||
| Exercise of stock options | ||||||||||||||||||||
| Shares issued under ESPP | ||||||||||||||||||||
| Shares issued for restricted stock units vested | ( | ) | ||||||||||||||||||
| Repurchase and retirement of stock | ( | ) | ( | ) | ( | ) | ||||||||||||||
| Share-based compensation expense | ||||||||||||||||||||
| Balance at September 26, 2020 | $ | $ | $ | $ | ( | ) | $ | |||||||||||||
The accompanying notes are an integral part of these statements.
| CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||||||
| (Unaudited) |
|||||||||
| (in thousands) |
| Nine Months Ended |
||||||||
| September 25, |
September 26, |
|||||||
| 2021 |
2020 |
|||||||
| Cash flows from operating activities: |
||||||||
| Net income (loss) |
$ | $ | ( |
) | ||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: |
||||||||
| Gain on business divestitures |
( |
) | ( |
) | ||||
| (Gain) loss on extinguishment of debt |
( |
) | ||||||
| Impairment charges related to indefinite lived intangibles |
||||||||
| Gain from sale of property, plant and equipment |
( |
) | ( |
) | ||||
| Depreciation and amortization |
||||||||
| Share-based compensation expense |
||||||||
| Non-cash inventory related charges |
||||||||
| Deferred income taxes |
( |
) | ||||||
| Changes in accrued retiree medical benefits |
( |
) | ||||||
| Changes in other accrued liabilities |
( |
) | ||||||
| Changes in other assets |
( |
) | ||||||
| Amortization of cloud-based software implementation costs |
||||||||
| Interest capitalized associated with cloud computing implementation |
( |
) | ( |
) | ||||
| Amortization of debt discounts and issuance costs |
||||||||
| Changes in assets and liabilities: |
||||||||
| Customer advances |
( |
) | ( |
) | ||||
| Accounts receivable |
( |
) | ||||||
| Inventories |
( |
) | ( |
) | ||||
| Other current assets |
( |
) | ||||||
| Accounts payable |
( |
) | ||||||
| Deferred profit |
||||||||
| Income taxes payable |
( |
) | ||||||
| Accrued compensation, warranty and other liabilities |
( |
) | ||||||
| Operating lease right-of-use assets |
||||||||
| Current and long-term operating lease liabilities |
( |
) | ( |
) | ||||
| Net cash provided by operating activities |
||||||||
| Cash flows from investing activities: |
||||||||
| Cash received from disposition of business, net of cash paid |
||||||||
| Cash received from sale of property, plant and equipment |
||||||||
| Purchases of short-term investments |
( |
) | ||||||
| Sales and maturities of short-term investments |
||||||||
| Purchases of property, plant and equipment |
( |
) | ( |
) | ||||
| Net cash provided by investing activities |
||||||||
| Cash flows from financing activities: |
||||||||
| Cash dividends paid |
( |
) | ||||||
| Repurchases of common stock, net |
( |
) | ( |
) | ||||
| Proceeds from revolving line of credit and construction loans |
||||||||
| Proceeds received from issuance of common stock, net of fees |
||||||||
| Repayments of long-term debt |
( |
) | ( |
) | ||||
| Net cash provided by (used in) financing activities |
( |
) | ||||||
| Effect of exchange rate changes on cash and cash equivalents |
( |
) | ||||||
| Net increase in cash and cash equivalents |
||||||||
| Cash and cash equivalents at beginning of period |
||||||||
| Cash and cash equivalents at end of period |
$ | $ | ||||||
| Supplemental disclosure of cash flow information: |
||||||||
| Cash paid for income taxes |
$ | $ | ||||||
| Inventory capitalized as property, plant and equipment |
$ | $ | ||||||
| Property, plant and equipment purchases included in accounts payable |
$ | $ | ||||||
| Capitalized cloud computing service costs included in accounts payable |
$ | $ | ||||||
| Cash paid for interest |
$ | $ | ||||||
The accompanying notes are an integral part of these statements.
| Summary of Significant Accounting Policies |
Basis of Presentation
Our fiscal years are based on a 52- or 53-week period ending on the last Saturday in December. The condensed consolidated balance sheet at December 26, 2020, has been derived from our audited financial statements at that date. The interim condensed consolidated financial statements as of September 25, 2021, (also referred to as “the third quarter of fiscal 2021” and “the first nine months of fiscal 2021”) and September 26, 2020, (also referred to as “the third quarter of fiscal 2020” and “the first nine months of fiscal 2020”) are unaudited. However, in management’s opinion, these financial statements reflect all adjustments (consisting only of normal, recurring items) necessary to provide a fair presentation of our financial position, results of operations and cash flows for the periods presented. Both the three- and nine-month periods ended September 25, 2021 and September 26, 2020, were comprised of 13 and 39 weeks, respectively.
Our interim results are not necessarily indicative of the results that should be expected for the full year. The condensed consolidated financial statements presented herein reflect estimates and assumptions made by management at September 25, 2021 and for the nine-month period ended September 25, 2021. For a better understanding of Cohu, Inc. and our financial statements, we recommend reading these interim condensed consolidated financial statements in conjunction with our audited financial statements for the year ended December 26, 2020, which are included in our 2020 Annual Report on Form 10-K, filed with the U. S. Securities and Exchange Commission (“SEC”). In the following notes to our interim condensed consolidated financial statements, Cohu, Inc. is referred to as “Cohu”, “we”, “our” and “us”.
All significant consolidated transactions and balances have been eliminated in consolidation.
Concentration of Credit Risk
Financial instruments that potentially subject us to significant credit risk consist principally of cash equivalents, short-term investments and trade accounts receivable. We invest in a variety of financial instruments and, by policy, limit the amount of credit exposure with any one issuer.
Our trade accounts receivable are presented net of an allowance for credit losses, which is determined in accordance with the guidance provided by Accounting Standards Update (“ASU”) 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. At September 25, 2021 and December 26, 2020 our allowance for credit losses was $
Inventories
Inventories are stated at the lower of cost, determined on a first-in, first-out basis, or net realizable value. Cost includes labor, material and overhead costs. Determining net realizable value of inventories involves numerous estimates and judgments including projecting average selling prices and sales volumes for future periods and costs to complete and dispose of inventory. As a result of these analyses, we record a charge to cost of sales in advance of the period when the inventory is sold when estimated net realizable values are below our costs.
Inventories by category were as follows (in thousands):
| September 25, | December 26, | |||||||
| 2021 | 2020 | |||||||
| Raw materials and purchased parts | $ | $ | ||||||
| Work in process | ||||||||
| Finished goods | ||||||||
| Total inventories | $ | $ | ||||||
Property, Plant and Equipment
Depreciation and amortization of property, plant and equipment, both owned and under financing lease, is calculated principally on the straight-line method based on estimated useful lives of to years for buildings, to years for building improvements and to years for machinery, equipment and software. Land is not depreciated.
Property, plant and equipment, at cost, consisted of the following (in thousands):
| September 25, | December 26, | |||||||
| 2021 | 2020 | |||||||
| Land and land improvements | $ | $ | ||||||
| Buildings and building improvements | ||||||||
| Machinery and equipment | ||||||||
| Less accumulated depreciation and amortization | ( | ) | ( | ) | ||||
| Property, plant and equipment, net | $ | $ | ||||||
Cloud-based Enterprise Resource Planning Implementation Costs
We have capitalized certain costs associated with the implementation of our new cloud-based Enterprise Resource Planning (“ERP”) system in accordance with Accounting Standard Codification (“ASC”) Topic 350, Intangibles—Goodwill and Other, (“ASC 350”). Capitalized costs include only external direct costs of materials and services consumed in developing the system and interest costs incurred, when material, while developing the system.
Unamortized capitalized cloud computing implementation costs totaled $
Segment Information
We applied the provisions of ASC Topic 280, Segment Reporting, (“ASC 280”), which sets forth a management approach to segment reporting and establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products, major customers and the geographies in which the entity holds material assets and reports revenue. An operating segment is defined as a component that engages in business activities whose operating results are reviewed by the chief operating decision maker and for which discrete financial information is available. We have determined that our
Goodwill and Indefinite-Lived Intangibles, Other Intangible Assets and Long-lived Assets
We evaluate goodwill and other indefinite-lived intangible assets, which are solely comprised of in-process research and development (“IPR&D”), for impairment annually and when an event occurs or circumstances change that indicate that the carrying value may not be recoverable. We test goodwill for impairment by first comparing the book value of net assets to the fair value of the reporting unit or, in the case of in-process research and development, to the fair value of the asset. If the fair value is determined to be less than the book value, a second step is performed to compute the amount of impairment as the difference between the fair value of the reporting unit and its carrying value, not to exceed the carrying value of goodwill. We estimated the fair values of our reporting units primarily using the income approach valuation methodology that includes the discounted cash flow method, taking into consideration the market approach and certain market multiples as a validation of the values derived using the discounted cash flow methodology. Forecasts of future cash flows are based on our best estimate of future net sales and operating expenses, based primarily on customer forecasts, industry trade organization data and general economic conditions. Fair value determinations require considerable judgment and are sensitive to changes in underlying assumptions and factors.
We conduct our annual impairment test as of October 1st of each year, and have determined there was
Long-lived assets, other than goodwill, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets might not be recoverable. Conditions that would necessitate an impairment assessment include a significant decline in the observable market value of an asset, a significant change in the extent or manner in which an asset is used, or any other significant adverse change that would indicate that the carrying amount of an asset or group of assets may not be recoverable. For long-lived assets, impairment losses are only recorded if the asset’s carrying amount is not recoverable through its undiscounted, probability-weighted future cash flows. We measure the impairment loss based on the difference between the carrying amount and estimated fair value.
Product Warranty
Product warranty costs are accrued in the period sales are recognized. Our products are generally sold with standard warranty periods, which differ by product, ranging from
Restructuring Costs
We record restructuring activities including costs for one-time termination benefits in accordance with ASC Topic 420 (“ASC 420”), Exit or Disposal Cost Obligations. The timing of recognition for severance costs accounted for under ASC 420 depends on whether employees are required to render service until they are terminated in order to receive the termination benefits. If employees are required to render service until they are terminated in order to receive the termination benefits, a liability is recognized ratably over the future service period. Otherwise, a liability is recognized when management has committed to a restructuring plan and has communicated those actions to employees. Employee termination benefits covered by existing benefit arrangements are recorded in accordance with ASC Topic 712, Nonretirement Postemployment Benefits. These costs are recognized when management has committed to a restructuring plan and the severance costs are probable and estimable. See Note 4, “Restructuring Charges” for additional information.
Debt Issuance Costs
We capitalize costs related to the issuance of debt. Debt issuance costs directly related to our Term Loan Credit Facility are presented within noncurrent liabilities as a reduction of long-term debt in our condensed consolidated balance sheets. The amortization of such costs is recognized as interest expense using the effective interest method over the term of the respective debt issue. Amortization related to deferred debt issuance costs and original discount costs was $
Foreign Remeasurement and Currency Translation
Assets and liabilities of our wholly owned foreign subsidiaries that use the U.S. Dollar as their functional currency are re-measured using exchange rates in effect at the end of the period, except for nonmonetary assets, such as inventories and property, plant and equipment, which are re-measured using historical exchange rates. Revenues and costs are re-measured using average exchange rates for the period, except for costs related to those balance sheet items that are re-measured using historical exchange rates. Gains and losses on foreign currency transactions are recognized as incurred. During the three and nine months ended September 25, 2021, we recognized foreign exchange losses of $
Foreign Exchange Derivative Contracts
We operate and sell our products in various global markets. As a result, we are exposed to changes in foreign currency exchange rates. We enter into foreign currency forward contracts with a financial institution to hedge against future movements in foreign exchange rates that affect certain existing U.S. Dollar denominated assets and liabilities held at our subsidiaries whose functional currency is the local currency. Under this program, our strategy is to have increases or decreases in our foreign currency exposures mitigated by gains or losses on the foreign currency forward contracts in order to mitigate the risks and volatility associated with foreign currency transaction gains or losses.
We do not use derivative financial instruments for speculative or trading purposes. For accounting purposes, our foreign currency forward contracts are not designated as hedging instruments and, accordingly, we record the fair value of these contracts as of the end of our reporting period in our condensed consolidated balance sheets with changes in fair value recorded within foreign transaction gain (loss) in our condensed consolidated statements of operations for both realized and unrealized gains and losses. See Note 7, “Derivative Financial Instruments” for additional information.
Share-Based Compensation
We measure and recognize all share-based compensation under the fair value method. Our estimate of share-based compensation expense requires a number of complex and subjective assumptions including our stock price volatility, employee exercise patterns (expected life of the options) and related tax effects. The assumptions used in calculating the fair value of share-based awards represent our best estimates, but these estimates involve inherent uncertainties and the application of management judgment. Although we believe the assumptions and estimates we have made are reasonable and appropriate, changes in assumptions could materially impact our reported financial results.
Reported share-based compensation is classified, in our condensed consolidated financial statements, as follows (in thousands):
| Three Months Ended | Nine Months Ended | |||||||||||||||
| September 25, | September 26, | September 25, | September 26, | |||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||
| Cost of sales | $ | $ | $ | $ | ||||||||||||
| Research and development | ||||||||||||||||
| Selling, general and administrative | ||||||||||||||||
| Total share-based compensation | ||||||||||||||||
| Income tax benefit | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Total share-based compensation, net | $ | $ | $ | $ | ||||||||||||
Income (Loss) Per Share
Basic income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the reporting period. Diluted income (loss) per share includes the dilutive effect of common shares potentially issuable upon the exercise of stock options, vesting of outstanding restricted stock and performance stock units and issuance of stock under our employee stock purchase plan using the treasury stock method. In loss periods, potentially dilutive securities are excluded from the per share computations due to their anti-dilutive effect. For purposes of computing diluted income (loss) per share, stock options with exercise prices that exceed the average fair market value of our common stock for the period are excluded. For the three and nine months ended September 25, 2021, stock options and awards to issue approximately
The following table reconciles the denominators used in computing basic and diluted income (loss) per share (in thousands):
| Three Months Ended | Nine Months Ended | |||||||||||||||
| September 25, | September 26, | September 25, | September 26, | |||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||
| Weighted average common shares | ||||||||||||||||
| Effect of dilutive securities | ||||||||||||||||
Cohu has utilized the “control number” concept in the computation of diluted earnings per share to determine whether potential common stock instruments are dilutive. The control number used is income from continuing operations. The control number concept requires that the same number of potentially dilutive securities applied in computing diluted earnings per share from continuing operations be applied to all other categories of income or loss, regardless of their anti-dilutive effect on such categories.
Leases
We determine if a contract contains a lease at inception. Operating leases are included in operating lease right of use (“ROU”) assets, current other accrued liabilities, and long-term lease liabilities on our condensed consolidated balance sheets. Finance leases are included in property, plant and equipment, other current accrued liabilities, and long-term lease liabilities on our condensed consolidated balance sheets.
Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the adoption date or the commencement date for leases entered into after the adoption date. As most of our leases do not provide an implicit rate, we use our incremental borrowing rates for the remaining lease terms based on the information available at the adoption date or commencement date in determining the present value of future payments.
The operating lease ROU asset also includes any lease payments made, lease incentives, favorable and unfavorable lease terms recognized in business acquisitions and excludes initial direct costs incurred and variable lease payments. Variable lease payments include estimated payments that are subject to reconciliations throughout the lease term, increases or decreases in the contractual rent payments, as a result of changes in indices or interest rates and tax payments that are based on prevailing rates. Our lease terms may include renewal options to extend the lease when it is reasonably certain that we will exercise those options. In addition, we include purchase option amounts in our calculations when it is reasonably certain that we will exercise those options. Rent expense for minimum payments under operating leases is recognized on a straight-line basis over the term.
Leases with an initial term of 12 months or less are not recorded on the balance sheet but recognized in our condensed consolidated statements of operations on a straight-line basis over the lease term. We account for lease and non-lease components as a single lease component and include both in our calculation of the ROU assets and lease liabilities.
We sublease certain leased assets to third parties, mainly as a result of unused space in our facilities. None of our subleases contain extension options. Variable lease payments in our subleases include tax payments that are based on prevailing rates. We account for lease and non-lease components as a single lease component.
Revenue Recognition
Our net sales are derived from the sale of products and services and are adjusted for estimated returns and allowances, which historically have been insignificant. We recognize revenue when the obligations under the terms of a contract with our customers are satisfied; generally, this occurs with the transfer of control of our systems, non-system products or services. In circumstances where control is not transferred until destination or acceptance, we defer revenue recognition until such events occur.
Revenue for established products that have previously satisfied a customer’s acceptance requirements is generally recognized upon shipment. In cases where a prior history of customer acceptance cannot be demonstrated or from sales where customer payment dates are not determinable and in the case of new products, revenue and cost of sales are deferred until customer acceptance has been received. Our post-shipment obligations typically include installation and standard warranties. The relative standalone selling price of installation related revenue is recognized in the period the installation is performed. Service revenue is recognized over time as we transfer control to our customer for the related contract or upon completion of the services if they are short-term in nature. Spares, contactor and kit revenue is generally recognized upon shipment.
Certain of our equipment sales have multiple performance obligations. These arrangements involve the delivery or performance of multiple performance obligations, and transfer of control of performance obligations may occur at different points in time or over different periods of time. For arrangements containing multiple performance obligations, the revenue relating to the undelivered performance obligation is deferred using the relative standalone selling price method utilizing estimated sales prices until satisfaction of the deferred performance obligation.
Unsatisfied performance obligations primarily represent contracts for products with future delivery dates. At September 25, 2021, we had $
We generally sell our equipment with a product warranty. The product warranty provides assurance to customers that delivered products are as specified in the contract (an “assurance-type warranty”). Therefore, we account for such product warranties under ASC 460, Guarantees (“ASC 460”), and not as a separate performance obligation.
The transaction price reflects our expectations about the consideration we will be entitled to receive from the customer and may include fixed or variable amounts. Fixed consideration primarily includes sales to customers that are known as of the end of the reporting period. Variable consideration includes sales in which the amount of consideration that we will receive is unknown as of the end of a reporting period. Such consideration primarily includes sales made to certain customers with cumulative tier volume discounts offered. Variable consideration arrangements are rare; however, when they occur, we estimate variable consideration as the expected value to which we expect to be entitled. Included in the transaction price estimate are amounts in which it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. Variable consideration that does not meet revenue recognition criteria is deferred.
Our contracts are typically less than one year in duration and we have elected to use the practical expedient available in ASC 606 to expense cost to obtain contracts as they are incurred because they would be amortized over less than one year.
Accounts receivable represents our unconditional right to receive consideration from our customer. Payments terms do not exceed one year from the invoice date and therefore do not include a significant financing component. To date, there have been no material impairment losses on accounts receivable. There were no material contract assets or contract liabilities recorded on our condensed consolidated balance sheet in any of the periods presented.
On shipments where sales are not recognized, gross profit is generally recorded as deferred profit in our condensed consolidated balance sheet representing the difference between the receivable recorded and the inventory shipped. At September 25, 2021, we had deferred revenue totaling approximately $
Net sales of our reportable segments, by type, are as follows (in thousands):
| Three Months Ended | Nine Months Ended | |||||||||||||||
| Disaggregated Net Sales | September 25, 2021 | September 26, 2020 | September 25, 2021 | September 26, 2020 | ||||||||||||
| Systems: | ||||||||||||||||
| Semiconductor Test & Inspection | $ | $ | $ | $ | ||||||||||||
| PCB Test | ||||||||||||||||
| Non-systems: | ||||||||||||||||
| Semiconductor Test & Inspection | ||||||||||||||||
| PCB Test | ||||||||||||||||
| Total net sales | $ | $ | $ | $ | ||||||||||||
Revenue by geographic area based upon product shipment destination (in thousands):
| Three Months Ended | Nine Months Ended | |||||||||||||||
| Disaggregated Net Sales | September 25, 2021 | September 26, 2020 | September 25, 2021 | September 26, 2020 | ||||||||||||
| China | $ | $ | $ | $ | ||||||||||||
| Philippines | ||||||||||||||||
| Taiwan | ||||||||||||||||
| Malaysia | ||||||||||||||||
| United States | ||||||||||||||||
| Rest of the World | ||||||||||||||||
| Total net sales | $ | $ | $ | $ | ||||||||||||
A small number of customers historically have been responsible for a significant portion of our net sales. Significant customer concentration information, by reportable segment, is as follows:
| Three Months Ended | Nine Months Ended | |||||||||||||||
| September 25, | September 26, | September 25, | September 26, | |||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||
| Semiconductor Test & Inspection | ||||||||||||||||
| Customers individually accounting for more than 10% of net sales |
| * |
|
| ||||||||||||
| Percentage of net sales | % | * | % | % | ||||||||||||
| PCB Test | ||||||||||||||||
| Customers individually accounting for more than 10% of net sales | N/A | * | * | * | ||||||||||||
| Percentage of net sales | N/A | * | * | * | ||||||||||||
| * | No single customer represented more than 10% of consolidated net sales. |
Accumulated Other Comprehensive Loss
Our accumulated other comprehensive loss balance totaled approximately $
Retiree Medical Benefits
We provide post-retirement health benefits to certain retired executives, one director (who is a former executive) and their eligible dependents under a noncontributory plan. These benefits are no longer offered to any other retired Cohu employees. The net periodic benefit cost incurred during the first nine months of fiscal 2021 and 2020 was not significant.
Business Divestitures and Discontinued Operations
On June 24, 2021, we completed the sale of our PCB Test Equipment (“PCB Test”) business, which represented our PCB Test segment. As part of the transaction we also sold certain intellectual property held by our Semiconductor Test & Inspection segment that is utilized by the PCB Test business. In February 2020, we divested our fixtures services business. Our decision to sell these businesses and assets resulted from management’s determination that that they were not a fit within the core business of our organization which is delivering leading-edge solutions for the manufacturing of semiconductors through back-end semiconductor equipment and services.
Unless otherwise indicated, all amounts herein relate to continuing operations. For financial statement purposes, only the results of operations of our fixtures services business have been segregated from those of continuing operations and have been presented in our consolidated financial statements as discontinued operations for all periods presented. See Note 12, “Business Divestiture and Discontinued Operations” for additional information on these transactions and financial statement presentation.
New Accounting Pronouncements
There have been no material changes in recently issued or adopted accounting standards from those disclosed in our Annual Report on Form 10-K for the fiscal year ended December 26, 2020.
| 2. | Goodwill and Purchased Intangible Assets |
Goodwill and Intangible Assets
Changes in the carrying value of goodwill during the year ended December 26, 2020, and the nine-month period ended September 25, 2021, by segment, were as follows (in thousands):
| Semiconductor Test | ||||||||||||
| & Inspection | PCB Test | Total | ||||||||||
| Balance, December 28, 2019 | $ | $ | $ | |||||||||
| Impact of currency exchange | ||||||||||||
| Balance, December 26, 2020 | ||||||||||||
| Sale of PCB Test business (1) | ( | ) | ( | ) | ||||||||
| Impact of currency exchange | ( | ) | ( | ) | ||||||||
| Balance, September 25, 2021 | $ | $ | $ | |||||||||
| (1) | On June 24, 2021, we completed the sale of our PCB Test business. See Note 12, “Discontinued Operations and Divestitures” for additional information. |
Purchased intangible assets, subject to amortization are as follows (in thousands):
| September 25, 2021 | December 26, 2020 | |||||||||||||||||||
| Remaining | ||||||||||||||||||||
| Weighted | ||||||||||||||||||||
| Gross | Average | Gross | ||||||||||||||||||
| Carrying | Accum. | Amort. | Carrying | Accum. | ||||||||||||||||
| Amount | Amort. | Period (in years) | Amount | Amort. | ||||||||||||||||
| Developed technology | $ | $ | $ | $ | ||||||||||||||||
| Customer relationships | ||||||||||||||||||||
| Trade names | ||||||||||||||||||||
| Covenant not-to-compete | ||||||||||||||||||||
| Total intangible assets | $ | $ | $ | $ | ||||||||||||||||
The table above excludes $
Other events and changes in circumstances may also require goodwill to be tested for impairment between annual measurement dates. During the first quarter of 2020, the volatility in Cohu’s stock price, the global economic downturn and business interruptions associated with the COVID-19 pandemic led us to determine that there was a triggering event related to goodwill within all of our identified reporting units and our indefinite-lived intangible assets. We performed an interim assessment as of March 28, 2020 and determined that the fair values of our identified reporting units all exceeded their carrying values and we concluded there was
Amortization expense related to intangible assets was approximately $
| 3. | Borrowings and Credit Agreements |
The following table is a summary of our borrowings (in thousands):
| September 25, | December 26, | |||||||
| 2021 | 2020 | |||||||
| Bank Term Loan under Credit Agreement | $ | $ | ||||||
| Bank Term Loans-Kita | ||||||||
| Construction Loan- Cohu GmbH | ||||||||
| Lines of Credit | ||||||||
| Total debt | ||||||||
| Less: financing fees and discount | ( | ) | ( | ) | ||||
| Less: current portion | ( | ) | ( | ) | ||||
| Total long-term debt | $ | $ | ||||||
Credit Agreement
On October 1, 2018, we entered into a Credit Agreement providing for a $
Under the terms of the Credit Agreement, the lender may accelerate the payment terms upon the occurrence of certain events of default set forth therein, which include: the failure of Cohu to make timely payments of amounts due under the Credit Agreement, the failure of Cohu to adhere to the representations and covenants set forth in the Credit Agreement, the failure to provide notice of any event that causes a material adverse effect or to provide other required notices, upon the event that related collateral agreements become ineffective, upon the event that certain legal judgments are entered against Cohu, the insolvency of Cohu, or upon the change of control of Cohu. As of September 25, 2021, we believe no such events of default have occurred.
During the first nine months of 2021, we prepaid $
Kita Term Loans
We have outstanding term loans from a series of Japanese financial institutions primarily related to the expansion of our facility in Osaka, Japan. The term loans are collateralized by the facility and land, carry interest rates ranging from
The term loans are denominated in Japanese Yen and, as a result, amounts disclosed herein will fluctuate because of changes in currency exchange rates.
Construction Loans
In July 2019 and June 2020, one of our wholly owned subsidiaries located in Germany entered into a series of construction loans (“Loan Facilities”) with a German financial institution providing it with total borrowings of up to €
The first facility totaling €
At September 25, 2021, total outstanding borrowings under the Loan Facilities was $
Lines of Credit
Our wholly owned subsidiary in Japan has outstanding revolving credit facilities with various financial institutions in Japan. The credit facilities renew monthly and provide Kita with access to working capital totaling up to $
The revolving lines of credit are denominated in Japanese Yen and, as a result, amounts disclosed herein will fluctuate because of changes in currency exchange rates.
Our wholly owned subsidiary in Switzerland has an available line of credit which provides it with borrowings of up to a total of
| 4. | Restructuring Charges |
Subsequent to the acquisition of Xcerra on October 1, 2018, during the fourth quarter of 2018, we began a strategic restructuring program designed to reposition our organization and improve our cost structure as part of our targeted integration plan regarding the recently acquired Xcerra (“Integration Program”). As part of the Integration Program we consolidated our global handler and contactor manufacturing operations and closed our manufacturing operations in Penang, Malaysia and Fontana, California in 2019.
In the second quarter of 2019, we entered into a social plan (“Plan”) with the German labor organization representing certain of the employees of our wholly owned subsidiary, Multitest elektronische Systeme GmbH, as part of our Integration Program. During the fourth quarter of 2020 we implemented a voluntary program and termination agreements with certain employees of our wholly owned subsidiary, Cohu GmbH. These programs will collectively reduce headcount, enable us to consolidate the facilities of our multiple operations located near Kolbermoor and Rosenheim, Germany, as well as transition certain manufacturing to other lower cost regions. The facility consolidations and reduction in force programs are being implemented as part of a comprehensive review of our operations and are intended to streamline and reduce our operating cost structure and capitalize on acquisition synergies.
As a result of the activities described above, we recognized total pretax charges of $
Costs associated with restructuring activities are presented in our condensed consolidated statements of operations as restructuring charges, except for certain costs associated with inventory charges related to the decision to end manufacturing of certain of Xcerra’s semiconductor test handler products, which are classified within cost of sales. Other restructuring costs include expenses for professional fees associated with employee severance, impairments of fixed assets and building close expenses.
The following table summarizes the activity within the restructuring related accounts for the Integration Program during the first nine months ended September 25, 2021 and September 26, 2020 (in thousands):
| Severance and | Other Exit | |||||||||||
| Other Payroll | Costs | Total | ||||||||||
| Balance, December 28, 2019 | $ | $ | ||||||||||